Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVAX |
---|---|---|
09:32 ET | 104544 | 12.32 |
09:34 ET | 71399 | 12.16 |
09:36 ET | 65194 | 12.12 |
09:38 ET | 65818 | 12.02 |
09:39 ET | 54451 | 12.037 |
09:41 ET | 74422 | 12.06 |
09:43 ET | 49011 | 12.1341 |
09:45 ET | 34664 | 12.2406 |
09:48 ET | 55544 | 12.27 |
09:50 ET | 45210 | 12.28 |
09:52 ET | 29259 | 12.24 |
09:54 ET | 22826 | 12.28 |
09:56 ET | 57838 | 12.2824 |
09:57 ET | 24063 | 12.27 |
09:59 ET | 21263 | 12.28 |
10:01 ET | 81255 | 12.39 |
10:03 ET | 43995 | 12.3301 |
10:06 ET | 18815 | 12.315 |
10:08 ET | 52791 | 12.28 |
10:10 ET | 18259 | 12.3 |
10:12 ET | 16742 | 12.358 |
10:14 ET | 21920 | 12.3 |
10:15 ET | 20811 | 12.27 |
10:17 ET | 27384 | 12.2156 |
10:19 ET | 25207 | 12.185 |
10:21 ET | 29529 | 12.168 |
10:24 ET | 14077 | 12.17 |
10:26 ET | 14572 | 12.17 |
10:28 ET | 13550 | 12.175 |
10:30 ET | 25218 | 12.12 |
10:32 ET | 21904 | 12.155 |
10:33 ET | 30293 | 12.17 |
10:35 ET | 20386 | 12.195 |
10:37 ET | 35582 | 12.16 |
10:39 ET | 29914 | 12.205 |
10:42 ET | 23307 | 12.145 |
10:44 ET | 21945 | 12.126 |
10:46 ET | 12317 | 12.1399 |
10:48 ET | 6705 | 12.16 |
10:50 ET | 14544 | 12.13 |
10:51 ET | 13077 | 12.1499 |
10:53 ET | 20838 | 12.06 |
10:55 ET | 20345 | 12.0599 |
10:57 ET | 25533 | 12.0328 |
11:00 ET | 8216 | 12.04 |
11:02 ET | 39885 | 12.0001 |
11:04 ET | 23285 | 12.03 |
11:06 ET | 4767 | 12.03 |
11:08 ET | 22492 | 12.13 |
11:09 ET | 10613 | 12.14 |
11:11 ET | 7862 | 12.125 |
11:13 ET | 15600 | 12.1387 |
11:15 ET | 6191 | 12.1301 |
11:18 ET | 7345 | 12.1489 |
11:20 ET | 3416 | 12.145 |
11:22 ET | 21387 | 12.145 |
11:24 ET | 7552 | 12.14 |
11:26 ET | 2511 | 12.13 |
11:27 ET | 5853 | 12.1012 |
11:29 ET | 850 | 12.105 |
11:31 ET | 19420 | 12.125 |
11:33 ET | 8618 | 12.145 |
11:36 ET | 4990 | 12.14 |
11:38 ET | 1300 | 12.14 |
11:40 ET | 12771 | 12.15 |
11:42 ET | 2958 | 12.135 |
11:44 ET | 10668 | 12.125 |
11:45 ET | 6783 | 12.1701 |
11:47 ET | 21371 | 12.235 |
11:49 ET | 5597 | 12.235 |
11:51 ET | 17251 | 12.24 |
11:54 ET | 12409 | 12.254 |
11:56 ET | 4000 | 12.2413 |
11:58 ET | 17783 | 12.205 |
12:00 ET | 3495 | 12.2001 |
12:02 ET | 8144 | 12.185 |
12:03 ET | 3725 | 12.175 |
12:05 ET | 12452 | 12.205 |
12:07 ET | 25957 | 12.245 |
12:09 ET | 12940 | 12.27 |
12:12 ET | 4077 | 12.236 |
12:14 ET | 8020 | 12.2 |
12:16 ET | 5390 | 12.21 |
12:18 ET | 7189 | 12.19 |
12:20 ET | 10256 | 12.235 |
12:21 ET | 4947 | 12.235 |
12:23 ET | 3399 | 12.205 |
12:25 ET | 6481 | 12.195 |
12:27 ET | 8578 | 12.205 |
12:30 ET | 10042 | 12.185 |
12:32 ET | 3853 | 12.16 |
12:34 ET | 4501 | 12.19 |
12:36 ET | 3121 | 12.19 |
12:38 ET | 1679 | 12.181 |
12:39 ET | 5290 | 12.175 |
12:41 ET | 1025 | 12.175 |
12:43 ET | 3516 | 12.165 |
12:45 ET | 1568 | 12.165 |
12:48 ET | 7386 | 12.175 |
12:50 ET | 100 | 12.1799 |
12:52 ET | 6465 | 12.15 |
12:54 ET | 21447 | 12.11 |
12:56 ET | 5717 | 12.1 |
12:57 ET | 7933 | 12.0812 |
12:59 ET | 1926 | 12.075 |
01:01 ET | 3509 | 12.07 |
01:03 ET | 8674 | 12.095 |
01:06 ET | 3864 | 12.105 |
01:08 ET | 2803 | 12.0914 |
01:10 ET | 2037 | 12.075 |
01:12 ET | 3158 | 12.065 |
01:14 ET | 9418 | 12.055 |
01:15 ET | 14662 | 12.0486 |
01:17 ET | 6112 | 12.0299 |
01:19 ET | 12426 | 12.025 |
01:21 ET | 55709 | 12.025 |
01:24 ET | 11766 | 12.015 |
01:26 ET | 2650 | 12.0184 |
01:28 ET | 22529 | 11.9901 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Novavax Inc | 1.9B | -4.3x | --- |
PTC Therapeutics Inc | 2.8B | -6.0x | --- |
ACADIA Pharmaceuticals Inc | 2.5B | 84.6x | --- |
Azenta Inc | 2.3B | -17.2x | --- |
Guardant Health Inc | 2.7B | -5.5x | --- |
P3 Health Partners Inc | 138.5M | -0.6x | --- |
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
---|---|
Revenue (TTM) | $987.7M |
Shares Outstanding | 160.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.04 |
EPS | $-2.76 |
Book Value | $-5.14 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -29.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.